Renoprotective Effects of Metabolic Surgery Versus GLP1 Receptor Agonists on Progression of Kidney Impairment in Patients with Established Kidney Disease
2024 · Annals of Surgery · 16 citations
https://doi.org/10.1097/sla.0000000000006379
H
Hamlet Gasoyan
Cleveland Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
55
Papers
578
Citations
13
h-index
16
i10-index
Hamlet Gasoyan is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Bariatric Surgery and Outcomes & Pharmacology and Obesity Treatment & Diabetes Treatment and Management. The author has an h-index of 13, co-authored 47 publications.
ORCID: 0000-0002-1627-9777Papers by this author
worksChanges in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation status
2025 · Obesity · 16 citations
https://doi.org/10.1002/oby.24331
Disparities in time to treatment with oral antimyeloma medications
2024 · Blood Cancer Journal · 0 citations
https://doi.org/10.1038/s41408-024-01128-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat